|
Upcoming New
Protocols
Last Update 8/25/2008
Scheduled for IRB
review Sept. 12, 2008
Cancer
Control
Treatment
CTSU
C40503
Protocol
Endocrine Therapy in
Combination with anti-VEGF Therapy: A
Randomized, Double-Blind, Placebo-Controlled
Phase III Trial of Endocrine Therapy Alone or
Endocrine Therapy Plus Bevacizumab (NSC
704865; IND 7921) For Women with Hormone
Receptor-Positive Advanced Breast Cancer
NCCTG MC0261
Protocol
Phase II Trial of Flavopiridol and Cisplatin in
Advanced Epithelial Ovarian and Primary
Peritoneal Carcinomas (NCI #5876)
NCCTG N0776
Protocol
Phase II Trial of AvastinŽ
in Combination with Sorafenib in Recurrent
GlioblastomaMultiforme
NCCTG N0733
Protocol
Phase II Trial of
Capecitabine and Lapatinib with or without
IMC-A12 in Patients with HER2 Positive Breast
Cancer Previously Treated with Trastuzumab and
an Anthracycline and/or a Taxane
NCCTG N0775
Protocol A Randomized Phase II Trial of
Temozolomide (TMZ) and
AvastinŽ
or
ABI-007/
Carboplatin (CBDCA) and
AvastinŽ
in Patients with Unresectable Stage IV Malignant
Melanoma
RTOG R0524
Protocol
A
Phase I/II Trial of a Combination of Paclitaxel
and Trastuzumab with Daily Irradiation or
Paclitaxel Alone with
Daily Irradiation Following Transurethral
Surgery for Non-Cystectomy Candidates with
Muscle-Invasive Bladder Cancer
|
